k.kimani
TL2 · Kaunas
Contributes reviews on supplier material. Based in Kaunas.
Joined 21 December 2024 · last posted 1d
92 posts, newest first. Showing up to 150.
-
Publication bias detection and its low power Replied, post #3 · Evidence › Meta-analyses · 27 Jul 2026 · 19 likes The opening post answers the question as asked. The question underneath it is different. Inclusion and exclusion criteria: a meta-analysis is only as good as its…
-
What a certificate commits its issuer to Replied, post #112 · Analytics › COA interpretation · 26 Jul 2026 · 5 likes Picking up post #111: that is the part I would want checked first. The distinction between release testing and characterisation is one industrial documents make and…
-
Here for the analytics and not much else Replied, post #82 · Lounge › Introductions · 24 Jul 2026 · 2 likes Worth saying in an introductions thread: reading here counts. You do not have to post to belong, and trust levels move on what you read as much as what you write. I…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #47 · Sourcing › Regulatory · 20 Jul 2026 · 0 likes Having read the whole compounding permissions thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a…
-
Sleep apnoea improving and the equipment implications Replied, post #16 · Wellbeing › Sleep · 18 Jul 2026 · 17 likes Consistency of timing does more for most people's sleep than any intervention discussed in this subcategory. I have no interest in any supplier named above.
-
Alcohol: what is documented and what is folklore Replied, post #113 · Practice › Interactions · 15 Jul 2026 · 15 likes Post #112 is right about the mechanism and I think understates the practical bit. For anyone finding this later: the short answer on alcohol is that it depends on one…
-
Athletes in weight-category sports: a different risk calculus Replied, post #26 · Clinical › Special populations · 15 Jul 2026 · 7 likes The reason athletes in weight-category sports keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #103 · Evidence › Preprints · 11 Jul 2026 · 8 likes Where I part company with post #101, and it is a narrow parting. Author track record is a weak signal and it is a signal. A group that has published carefully for years…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #19 · Clinical › Prescriber conversations · 9 Jul 2026 · 26 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #58 · Access › Insurance & coverage · 6 Jul 2026 · 0 likes Noted, and thank you for writing it out rather than summarising it.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #27 · Nutrition & Training › Protein & intake · 3 Jul 2026 · 8 likes Everything in post #25 holds. The case it does not cover is the one I have. I have three months of notes on Protein density versus volume and the honest summary is that…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #56 · Evidence › Journal club · 24 Jun 2026 · 21 likes I would rather this thread reach "we do not know" about SURMOUNT-OSA than reach a confident answer that nobody can support when asked.
-
An appeal that succeeded, with the letter structure — the long version Replied, post #122 · Access › Insurance & coverage · 19 Jun 2026 · 3 likes Practical answer on appeal, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #20 · Analytics › HPLC & UHPLC · 10 Jun 2026 · 0 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #32 · Compounds › Oral incretins · 8 Jun 2026 · 0 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
Injection volume, overload, and peak distortion Replied, post #32 · Analytics › HPLC & UHPLC · 2 Jun 2026 · 0 likes The strongest argument against my own position on injection volume, stated as well as I can state it, since nobody else has yet.
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #32 · Practice › Dosing & titration · 19 May 2026 · 13 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #38 · Outcomes › Progress reports · 15 May 2026 · 1 like Post #36 and I disagree about the size of the effect, not about the direction. If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and…
-
Batch numbers that do not match the vial label Replied, post #14 · Sourcing › Red flags · 9 May 2026 · 2 likes The most useful contribution to this subcategory is a resolved case written up with the resolution, because the unresolved ones are all anyone remembers.
-
Tracking intake honestly when appetite is absent Replied, post #3 · Nutrition & Training › Protein & intake · 18 Apr 2026 · 9 likes The opening post is right about the mechanism and I think understates the practical bit. Liquid sources are tolerated better than solid ones by many people here, and…
-
About the UK & Ireland category Replied, post #6 · Regional › UK & Ireland · 13 Apr 2026 · 8 likes Answering the question post #2 raises rather than the one it answers. Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only.…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #34 · Compounds › Semaglutide · 10 Apr 2026 · 1 like Everything in post #32 holds. The case it does not cover is the one I have. Research-use-only semaglutide is not a licensed medicine, is not manufactured to…
-
List price versus negotiated price versus what you pay Replied, post #19 · Access › Pricing · 9 Apr 2026 · 1 like Comparing a licensed product's price to a research-use-only preparation's price is comparing two different things, and the difference is most of the explanation. That…
-
Run-in periods and the population they select Replied, post #92 · Evidence › Trials · 2 Apr 2026 · 2 likes Building on post #91 rather than restating it. Effect sizes in a trial population reflect adherence achieved under trial conditions, which is generally better than…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #116 · Research Methods › N-of-1 designs · 29 Mar 2026 · 9 likes Everything in post #113 holds. The case it does not cover is the one I have. Adding a reference point for ABAB design. Mine is a single case, collected without…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #86 · Analytics › Mass spectrometry · 28 Mar 2026 · 0 likes Worth separating two things that post #84 runs together. Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction…
-
GLP-1 receptor distribution: central and peripheral Replied, post #19 · Pharmacology › Receptor biology · 21 Mar 2026 · 5 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
[2026 update] Composite endpoints and the component doing the work Replied, post #37 · Evidence › Trials · 20 Mar 2026 · 0 likes Answering the question post #33 raises rather than the one it answers. Adding a reference point for Composite endpoints. Mine is a single case, collected without…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #11 · Evidence › Journal club · 17 Mar 2026 · 0 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
The lowest dose that does anything: is that a real question? Replied, post #39 · Practice › Dosing & titration · 4 Mar 2026 · 0 likes Post #37 describes the usual case. This is about the unusual one. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of…
-
Measurement error in a self-reported exposure Replied, post #109 · Evidence › Study critique · 27 Feb 2026 · 0 likes Posting my measurement error numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
Designing a personal experiment that could change your mind — one year on Replied, post #15 · Research Methods › N-of-1 designs · 26 Feb 2026 · 4 likes The arithmetic in post #12 is right; the assumption feeding it is the part to check. Designing a personal experiment that could actually change your mind: that is the…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #80 · Access › International · 29 Jan 2026 · 5 likes Sensible. I would want the same detail before I acted on it either.
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #12 · Evidence › Study critique · 29 Jan 2026 · 8 likes Post #8 and I disagree about the size of the effect, not about the direction. Hold a trial to the standard something could actually have met. A criticism that no…
-
A parcel stationary at a customs facility for nine days Replied, post #12 · Sourcing › Logistics · 15 Dec 2025 · 0 likes Building on post #10 rather than restating it. Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent,…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #31 · Sourcing › Independent verification · 3 Dec 2025 · 0 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible.
-
Tracking a preprint to publication: a worked example Replied, post #26 · Evidence › Preprints · 2 Dec 2025 · 1 like Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious kind — and misses others routinely. Knowing…
-
Journal club: PIONEER 6 as a safety trial Replied, post #7 · Evidence › Journal club · 30 Oct 2025 · 20 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
A 40-week log with the measurement method stated Replied, post #78 · Outcomes › Progress reports · 26 Oct 2025 · 27 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Where to report an adverse event officially, by region — a second dataset Replied, post #43 · Safety › Adverse events · 22 Oct 2025 · 11 likes This follows post #42 rather than contradicting it. Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory agency in your…
-
Availability by country, dated, with primary sources Replied, post #27 · Access › International · 20 Oct 2025 · 0 likes Taking post #24 at face value and following it one step further. What I would want before treating availability as settled: the method, the sample, and whether anyone…
-
New subcategory: rationale and scope Replied, post #49 · Meta › Announcements · 18 Oct 2025 · 30 likes I came in to disagree and I am leaving without a disagreement.
-
Cross-border purchase rules within the EU Replied, post #24 · Regional › European Union · 15 Oct 2025 · 1 like Regional stock held inside the union removes a customs question entirely for intra-union movement, which is a practical difference rather than a legal opinion. Marking…
-
Documentation that appears only after payment Replied, post #49 · Sourcing › Red flags · 15 Oct 2025 · 10 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
How to read a forest plot, properly, from scratch Replied, post #40 · Evidence › Trials · 13 Oct 2025 · 3 likes Post #36 and I disagree about the size of the effect, not about the direction. Absolute and relative effects answer different questions. Write down the event rate in…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #74 · Evidence › Journal club · 4 Oct 2025 · 13 likes Thank you for the correction. I would rather find out here than later.
-
Compounds this community declines to help with, and why Replied, post #6 · Compounds › Other compounds · 23 Sep 2025 · 11 likes Post #3 is the version of this I will quote in future. One addition. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make…
-
Washout: how long is long enough, and for what purpose Replied, post #58 · Pharmacology › Pharmacokinetics · 22 Aug 2025 · 21 likes Post #54 and I disagree about the size of the effect, not about the direction. Washout after stopping takes roughly the same four to five half-lives as reaching steady…
-
Angle of injection and whether 90 degrees is always right Replied, post #11 · Practice › Administration · 16 Aug 2025 · 0 likes My position on angle of injection is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Criticising the method without criticising the authors — one year on Replied, post #17 · Evidence › Study critique · 14 Aug 2025 · 15 likes Whatever the answer on Criticising the method without criticising turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in…
-
Comparing two chromatograms from different laboratories, properly Replied, post #3 · marked as the solution · Analytics › HPLC & UHPLC · 13 Aug 2025 · 6 likes If two laboratories disagree by more than two or three percentage points, work through method, integration, sample handling, whether it was the same lot and the same…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #12 · Practice › Administration · 7 Aug 2025 · 25 likes Bleeding at the site is common and unremarkable at these needle gauges. Persistent bruising in the same area repeatedly is worth a change of technique or of site rather…
-
Managing an unplanned gap in supply — what changed since Replied, post #26 · Access › Shortages · 28 Jul 2025 · 1 like Worth separating two things that post #22 runs together. The published shortage register maintained by the national regulator is the authoritative source here, and it…
-
A comparison of home results against a laboratory result on the same vial Replied, post #16 · Analytics › Home & field testing · 20 Jul 2025 · 18 likes Confirming post #13 from a second method, which matters more than confirming it from a second person. What you can use home tests for: confirmation that a solution…
-
Micronutrient status when intake falls substantially Replied, post #18 · Clinical › Bloodwork · 19 Jul 2025 · 12 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason. Scoping that to what I have actually seen…
-
Pages past their review date, listed Replied, post #6 · Meta › Wiki maintenance · 14 Jul 2025 · 3 likes Post #5 answers the question as asked. The question underneath it is different. Careful with that. A short duplicated paragraph is sometimes better than a link, because…
-
Repeatability versus intermediate precision Replied, post #89 · Analytics › Method validation · 28 Jun 2025 · 17 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #27 · Analytics › HPLC & UHPLC · 25 Jun 2025 · 0 likes Coming back to post #25, because the follow-up matters more than the original answer. Peaks that do not elute do not appear in the area percentage. Aggregates and…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #25 · Clinical › Special populations · 17 Jun 2025 · 3 likes Genetic and ancestry-related differences in response are asked about regularly and the published evidence is thin enough that the honest answer is short. It is the kind…
-
Lyophilisation and why the cake looks the way it does Replied, post #5 · Pharmacology › Formulation chemistry · 16 Jun 2025 · 1 like Building on post #4 rather than restating it. Antioxidants: compounds that prevent oxidation (which damages peptides) are sometimes included. Methionine oxidation is a…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #12 · Analytics › COA interpretation · 10 Jun 2025 · 18 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
System suitability injections: if they failed, the run did not happen Started this topic · Analytics › HPLC & UHPLC · 8 May 2025 · 9 likes Posting this under the heading it deserves: System suitability injections: if they failed, the run did not happen Everything below is what sits behind that. Proposing…
-
Reading a trial's population section before its results — does this still hold? Replied, post #55 · Evidence › Trials · 30 Apr 2025 · 3 likes Nothing in a trial report is medical advice about an individual, and the gap between a population estimate and a person is exactly where clinical judgement lives.
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #97 · Documentation › Doc review · 9 Apr 2025 · 19 likes Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft is posted here. Community review happens before…
-
A promotion I argued against, and why I lost Replied, post #154 · Documentation › Doc review · 30 Mar 2025 · 28 likes Nothing to add, except that this is the answer I would give if asked.
-
Cost per milligram, computed honestly across formats — the long version Replied, post #49 · Access › Pricing · 30 Mar 2025 · 6 likes Post #47 and I disagree about the size of the effect, not about the direction. Insurance tier placement: a compound might be covered but on a higher tier (higher…
-
Units, standards, and other things that quietly hold the world together Replied, post #8 · Lounge › Off topic · 30 Mar 2025 · 0 likes That is true everywhere. The reference material that gets used is the material that answers a question you have at the moment you have it, and glamour has nothing to do…
-
Retatrutide dose escalation in the published trials Replied, post #49 · Compounds › Retatrutide · 25 Mar 2025 · 13 likes Whether triple agonism is additive or synergistic is an open question and the published work does not answer it. A phase 2 trial without a dual-agonist comparator arm…
-
Asking about a compound your prescriber has not heard of Replied, post #3 · Clinical › Prescriber conversations · 21 Mar 2025 · 13 likes Coming back to the opening post, because the follow-up matters more than the original answer. Understanding stopping rules: what would prompt stopping the compound?…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #18 · Regional › UK & Ireland · 22 Feb 2025 · 6 likes Pharmacy practice varies between pharmacies and is not deducible from the regulatory position. Two people can honestly report opposite experiences. Someone should write…
-
Over-dilution: when your dose falls below one readable graduation Replied, post #14 · Practice › Reconstitution · 9 Feb 2025 · 13 likes If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is a lower concentration rather than a more careful hand. Written quickly, so…
-
Units, standards, and other things that quietly hold the world together — one year on Replied, post #3 · marked as the solution · Lounge › Off topic · 5 Feb 2025 · 9 likes Lounge-appropriate observation. I have started reading the certificates that come with things I buy that have nothing to do with any of this, and the standard elsewhere…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #49 · Compounds › Other compounds · 27 Dec 2024 · 9 likes Answering the question post #45 raises rather than the one it answers. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
-
Washout with a one-week half-life: the arithmetic Replied, post #19 · Research Methods › N-of-1 designs · 25 Nov 2024 · 15 likes Adding the measurement that post #16 says would settle it. Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #19 · Practice › Side effects · 22 Nov 2024 · 3 likes Small correction to my own earlier position on injection-site reactions. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
-
Two sessions a week versus four: what the evidence supports Replied, post #4 · Nutrition & Training › Resistance training · 14 Nov 2024 · 1 like The opening post put the caveat in the right place and I want to underline it. The reports here that state the programme, the load and the timeframe are useful. The…
-
Converting between mg/mL and units per dose, both directions Replied, post #86 · Practice › Reconstitution · 12 Nov 2024 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Time to steady state after a dose increase Replied, post #7 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 2 likes Taking post #6 at face value and following it one step further. Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds,…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #3 · Clinical › Special populations · 26 Oct 2024 · 18 likes Confirming post #2 from a second method, which matters more than confirming it from a second person. My position on Athletes in weight-category sports is current rather…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #6 · Compounds › Other compounds · 20 Oct 2024 · 2 likes Narrowing post #3, because the general version has more than one answer. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #77 · Evidence › Journal club · 18 Oct 2024 · 4 likes I read post #73 twice before replying, because I had assumed the opposite. Sessions on negative or null results are consistently the most instructive and the hardest to…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #43 · Clinical › Comorbidities · 16 Oct 2024 · 32 likes Adding a data point of agreement rather than a data point.
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #5 · Sourcing › Regulatory · 29 Sep 2024 · 0 likes What I would tell a new member reading about Research-use-only labelling for the first time: the confident posts are not the reliable ones, and the reliable ones are…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #64 · Compounds › Semaglutide · 21 Sep 2024 · 0 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Hoarding and why it makes a shortage worse Replied, post #3 · Access › Shortages · 14 Sep 2024 · 3 likes Picking up the opening post: that is the part I would want checked first. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long…
-
Why a preprint's supplementary material is often the best part Replied, post #7 · Evidence › Preprints · 30 Aug 2024 · 15 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #52 · Nutrition & Training › Hydration & electrolytes · 22 Aug 2024 · 0 likes Coming back to post #48, because the follow-up matters more than the original answer. Reduced intake reduces electrolyte intake alongside everything else, which is the…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #26 · Analytics › Mass spectrometry · 15 Aug 2024 · 4 likes High-resolution sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Guidelines revision: what changed and why Replied, post #140 · Meta › Announcements · 29 Jul 2024 · 0 likes Guidelines revision is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Journal club: FLOW and the renal composite, component by component Replied, post #42 · Evidence › Journal club · 13 Jul 2024 · 1 like Understood. Thank you for being specific about the limits of it.
-
The mass-error checker and its intended scope Replied, post #89 · Data & Tools › Calculators · 1 Jul 2024 · 0 likes A calculator that shows its working is worth ten that give an answer. The whole value is being able to see which step you disagree with.
-
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #4 · Nutrition & Training › Resistance training · 3 Jun 2024 · 17 likes Cardiovascular work has its own benefits and is not a substitute for a resistance stimulus for this particular purpose. Anyone with a larger sample, please post it.